Elizabeth Znameroski

This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Novozymes, Inc., Novozymes A/s. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Znameroski. Retrieved from https://idiyas.com/inventor/elizabeth-znameroski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331332 - GH61 variants and polynucleotides encoding same (2025-06-17),

2. 11891637 - GH61 polypeptide variants and polynucleotides encoding same (2024-02-06),

3. 11345905 - GH61 polypeptide variants and polynucleotides encoding same (2022-05-31),

4. 10227579 - GH61 polypeptide variants and polynucleotides encoding same (2019-03-12),

Title: The Innovative Journey of Elizabeth Znameroski in Biochemistry

Introduction

Elizabeth Znameroski is a notable inventor based in Davis, California, who has made significant contributions to the field of biochemistry. With a remarkable portfolio of four patents, she has demonstrated her dedication to advancing scientific knowledge and practical applications in her area of expertise.

Latest Patents

One of Elizabeth’s latest inventions focuses on GH61 polypeptide variants and their corresponding polynucleotides. The present invention relates to the development of GH61 polypeptide variants, alongside polynucleotides encoding these variants. It also covers nucleic acid constructs, vectors, and host cells that comprise the polynucleotides, as well as methods to utilize these variants effectively.

Career Highlights

Throughout her career, Elizabeth Znameroski has been affiliated with prominent companies, notably Novozymes, Inc. and Novozymes A/S. Her work within these organizations has led to significant advancements in biochemistry, showcasing her capability as a leading innovator in the industry.

Collaborations

Elizabeth has collaborated with esteemed colleagues such as Janine Lin and Doreen Bohan. Together, they have pushed the boundaries of research and development, contributing to the advancement of their field.

Conclusion

Elizabeth Znameroski’s innovative spirit and dedication to her field are evident through her patents and collaborations. Her ongoing work continues to shape the landscape of biochemistry, inspiring future generations of inventors and researchers.

Profile summary based on public USPTO records.